USD 23.71
(-2.39%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 62.23 Million USD | -9.61% |
2022 | 68.84 Million USD | 20.58% |
2021 | 57.09 Million USD | 48.42% |
2020 | 38.46 Million USD | 35.27% |
2019 | 28.43 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 56.45 Million USD | -9.29% |
2024 Q2 | 53.34 Million USD | -5.5% |
2023 FY | 62.23 Million USD | -9.61% |
2023 Q1 | 64.41 Million USD | -6.44% |
2023 Q2 | 59.83 Million USD | -7.11% |
2023 Q4 | 62.23 Million USD | -2.17% |
2023 Q3 | 63.61 Million USD | 6.32% |
2022 Q1 | 64.25 Million USD | 12.54% |
2022 FY | 68.84 Million USD | 20.58% |
2022 Q4 | 68.84 Million USD | -2.44% |
2022 Q3 | 70.57 Million USD | -0.31% |
2022 Q2 | 70.79 Million USD | 10.18% |
2021 Q3 | 51.44 Million USD | 11.26% |
2021 Q2 | 46.23 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 57.09 Million USD | 10.99% |
2021 FY | 57.09 Million USD | 48.42% |
2020 FY | 38.46 Million USD | 35.27% |
2020 Q4 | 38.46 Million USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 28.43 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Alcon Inc. | 2.32 Billion USD | 97.319% |
AptarGroup, Inc. | 513.05 Million USD | 87.87% |
Baxter International Inc. | 2.82 Billion USD | 97.796% |
Becton, Dickinson and Company | 3.27 Billion USD | 98.099% |
Bausch + Lomb Corporation | 1.02 Billion USD | 93.946% |
Haemonetics Corporation | 317.2 Million USD | 80.38% |
Envista Holdings Corp | 258.8 Million USD | 75.953% |
ResMed Inc. | 822.25 Million USD | 92.431% |
Teleflex Incorporated | 626.21 Million USD | 90.062% |
West Pharmaceutical Services, Inc. | 434.7 Million USD | 85.683% |